Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 2;14:1113932. doi: 10.3389/fimmu.2023.1113932

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Lesteberg, Araya, Waugh, Chauhan, Espinosa and Beckham

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Severe and recovered COVID-19 patients have greater frequencies of CD62L+ T cells. The frequencies of CD4+ and CD8+ T cells (viable, CD14-, CD56-, CD19-, CD3+, CD4+ or CD8+ cells) expressing CD62L in non-severe and severe COVID-19 patients, recovered COVID-19 patients, and healthy controls were assessed by flow cytometry. (A) CD62L+ CD4+ T cells and representative flow cytometry plots. Each plot represents a different patient; percentages of CD4+ CD62L+ CD27+ cells (B), CD4+ CD62L+ CTLA-4+ cells (C), CD4+ CD62L+ PD-1+ cells (D), CD8+ CD62L+ cells and representative flow plots (E), and CD8+ CD62L+ CD27+ cells (F) within the total CD4+ T cell (A-D) and CD8+ T cell (E, F) populations; *p<0.05, **p<0.01 one-way ANOVA with multiple comparisons correction. Data are graphed as percentages of the total CD4+ or CD8+ T cell population.